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ABSTRACT
Objective The rheumatology department at The
Royal Oldham Hospital developed a primary care
service aimed at bridging the gap between primary
and secondary care for patients with potential
rheumatological conditions, and this was given
the name rheumatology Tier 2. The objective of
this study was to evaluate this primary care rheu-
matology service (Tier 2) in order to assess its
validity, patient satisfaction and eﬀectiveness.
Design Ten patients participated in individual
semi-structured interviews. Three GPs were inter-
viewed individually, and two GPs formed a focus
group. Thematic analysis was used to interpret the
ﬁndings.
Setting Patients were recruited from seven con-
secutive rheumatology Tier 2 clinics. GPs were
recruited from Oldham Primary Care Trust (PCT)
as this was the main source of patient referrals for
the service.
Results The key ﬁndings were in relation to the
integration of primary healthcare and hospital ser-
vices, i.e. the primary/secondary care interface. This
highlighted the importance of early assessment,
diagnosis and treatment of patients with suspected
inﬂammatory arthritis.
Conclusion Early diagnosis and treatment with
disease-modifying anti-rheumatic drugs improves
patients’ outcomes. The rheumatology Tier 2 ser-
vice built on this evidence and provided a rapid
assessment and referral to secondary care for those
patients with suspected inﬂammatory arthritis.
Keywords: primary care development, primary/
secondary care interface, rheumatology, Tier 2 service
How this ﬁts in with quality in primary care
What do we know?
Early assessment, diagnosis and treatment of patients with suspected inﬂammatory arthritis has been shown
to improve outcomes for these patients.
What does this paper add?
Evaluation of a new rheumatology service showed that patients and general practitioners felt that it provided
a rapid assessment and referral to secondary care for those patients with suspected inﬂammatory arthritis.
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Introduction
Traditionally, patients with suspected inﬂammatory
arthritis are referred directly from their general prac-
titioner (GP) to a consultant in secondary care. How-
ever, innovations in practice together with recent
government policies are proliferating at the primary/
secondary care interface, aﬀecting referral pathways
and resource use.1 The principal motive for such
reorganisation is to move away from reactive care
based in acute systems, towards a systematic patient-
centred approach rooted in primary care.
Early diagnosis and treatment of inﬂammatory
arthritis with disease-modifying anti-rheumatic drugs
(DMARDs) has been shown to improve patient out-
comes.2 A large body of published material suggests
that DMARDs should be initiated within 3 months of
disease onset.3,4 In current practice the time from
symptom onset to commencement of DMARDs is at
best sixmonths.5 It is evident that considerable resources
are required to enable primary and secondary care
services to deliver DMARDs within the recommended
time scale.
Background
Research has shown that rheumatology services can be
managed safely within a primary care setting, not-
withstanding appropriate support from secondary
care.6 There is evidence that patients seen in a primary
care setting are managed relatively similarly and have
the same treatment outcomes to patients who are seen
and treated in secondary care.7 Based on these ﬁnd-
ings, the emergence of new initiatives to manage the
demand for rheumatological disorders occurs largely
at the primary/secondary care interface, rather than
solely within primary care.
In May 2003, the rheumatology team at The Royal
Oldham Hospital undertook a three-month audit of
new patient referrals. From the initial audit ﬁndings
it was estimated that approximately 40% of the new
patient referrals could be seen and treated in primary
care by a multidisciplinary team. As part of ongoing
developments in the management of chronically ill
patients, Oldham PCT established a primary care-
based rheumatology service (named Tier 2). The aim
of the service was to improve care pathways for
patients and reduce waiting times for secondary care
rheumatology patients.
This study was a nine-month evaluation of the
rheumatology Tier 2 service; it was commenced 12
months after the service began. Because this type of
servicewas new to the specialty of rheumatology, there
was a desire from the outset to combine best practice
with innovation and this was recently recognised when
the British Society of Rheumatology awarded ﬁrst
place to this service. The award ‘Innovation in Rheu-
matology’ was designed to highlight innovation and
excellence that has beneﬁted rheumatology medicine.
Methods
A qualitative descriptive analysis was used to evaluate
patient and GP responses to their experience of the
Tier 2 service. The data were analysed and categorised
by frequency, which allowed theories to be developed
oﬀering insight and enhanced understanding of the
data, and provided ameaningful guide of action to the
research situation.8,9
It was hoped that the service users’ perspective
would provide a patient-led direction, highlight areas
for development and improvement, andmost import-
antly, support evidence-based research and conﬁrm
that the rheumatology Tier 2 service was right for this
patient group. The GP sample provided a diﬀerent
perspective on the service users’ experience – it was
important to determine if the service oﬀered a quicker
response rate of treatment, improved patient out-
comes, and changed rheumatology delivery for the
better.
All patients who had a rheumatology Tier 2 ap-
pointment on seven consecutive clinic dates were sent
an invitation letter, information sheet and reply slip
inviting them to attend an interview lasting approx-
imately 30 minutes and consisting of semi-structured
questions, which referred to the rheumatology Tier 2
service and their evaluation of it. A total of 32 patient
invitations were sent. Thirteen patients agreed to take
part in this study. Non-responders were not sent
reminders due to time constraints of the study. One
patient was included in a pilot study and two patients
withdrew from the study on the interview date due to
prior commitments. The interview was conducted
after the patient’s rheumatology Tier 2 appointment
in an NHS setting.
The GP sample was originally intended to form a
focus group, and invitations were sent out via email as
it was fast and, more importantly, ensured direct
access to all of the GPs. To access the GP population
for this study, all GPs in the Oldham PCT were
emailed an invitation letter and the research protocol;
two weeks later a reminder email was sent. Eighty-
seven GPs were invited to attend the focus group
session. The ﬁrst six GPs who replied positively to
the email were to be included in the focus group and
the GPs were informed of this in their invitation. Two
GPs agreed to attend the focus group on the date
arranged, however, six GPs expressed an interest but
could not attend, as it was diﬃcult to organise a
mutually agreeable time.
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Due to the small number of participants for the GP
focus group, it was decided to interview individual
GPs, as they would be less constrained by a rigid time.
The most expedient process to gain access for the
individual interviews was to repeat the process of
emailing the previous six GPs who could not attend
the focus group due to time constraints. The email
asked if they would consider being interviewed about
their experiences of the rheumatology Tier 2 service
on an individual basis at their own GP practice at a
convenient time for them. Three of the six GPs replied
positively to this invitation and were interviewed
individually.
The setting for the GP focus group was a quiet,
relaxed room in the education centre at The Royal
Oldham Hospital. The individual GP interviews were
held in private in the GP’s own surgery.
Written informed consent was obtained from all
participants. All interviews and the focus group were
tape-recorded and transcribed. The data were stored
in a locked ﬁling cabinet in a locked oﬃce and were
destroyed after the completion of the study.
Results
Before the Tier 2 service, patients had to wait up to
13 weeks for an initial assessment in secondary care.
After introduction of the new service this was no
longer the case; because of the rapid-assessment pro-
cess, patients now had access to valuable medication
sooner. DMARDs are generally eﬀective, but they take
up to 12 weeks before they exert a therapeutic eﬀect;
and this was another reason to prescribe them early.2
The diﬀerence between primary and secondary care
in the delivery of rheumatological care was evident.
The primary care service hadmore direct care pathways –
patients were seen, treated and discharged with a plan
of care, usually within four weeks of receiving the GP
referral. The eﬀectiveness of the service in terms of its
ability to discharge patients was a crucial factor in the
services’ success. However, if patients had a suspected
inﬂammatory disease, their investigations were carried
out before they were referred on to secondary care.
Thismeant that when they had a hospital consultation
much of their diseasemanagement had started. There-
fore as one GP observed, the Tier 2 service provided
a bridge in the hiatus between early diagnosis and
treatment:
‘We don’t want to leave it too late to refer if they are going
to be rheumatoid because they need aggressive treatment
but we don’t want to send them in too early before it’s
clear as to what is going on.’
Given that 90% of patients with rheumatoid arthritis
have some form of disability within two decades of
onset,10 early diagnosis and treatment is of paramount
importance. Early diagnosis and treatment dramat-
ically improve patients’ long-term outcomes,2 and
ﬁndings showed that the Tier 2 service saw patients
early on in the disease process and started DMARDs
quickly. This was important also if the patient was to
return to a productive way of life, and was certainly a
consideration for the GPs:
‘What is the ﬁnal outcome for these individuals, does it
really change their quality of life, do they stay in work and
can they be a productive member of society?’
Healthcare resources are ﬁnite.11 Therefore infor-
mation about costs and eﬀectiveness were essential
when making decisions about the Tier 2 service. One
consideration from a GP was that if primary care
services are more cost-eﬀective and treatment is oﬀered
in the community then ﬁnancially the service is more
viable. On the other hand, another GP observed that
cost would be the same as the servicewas the samewith
only a diﬀerent setting.
‘Economically if it can be delivered much more speedily
and the likelihood is that the cost to theNHS is going to be
considerably less.’
In respect of setting, however, the patient ﬁndings
showed that this change had the greatest impact:
‘For some people it’s probably less threatening than
having to go to the hospital, you know it’s more of a
familiar sort of surrounding.’
Patients stated some concerns regarding attending a
primary care rheumatology service, but there was a
shift in opinion after their appointment where they
expressed a preference for the primary care service
instead of one based at the hospital. One explanation
given for this change in opinion was the similarity of
the assessment in primary care compared to secondary
care:
‘I mean the interview that I’ve had was very thorough and
I wouldn’t have thought it would have been any more
thorough at the hospital.’
The development of the Tier 2 service helped both the
patient and the healthcare professional to better deﬁne
the patients’ care pathway and ensure a quicker
response of evidence-based care. The shift from sec-
ondary- to primary-based care in the treatment of
rheumatology helped to respond to the local popu-
lation’s needs and provide a service that was as
accessible as possible,1 while being cost-eﬀective at
the same time.
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Discussion
Findings revealed that GP and patient satisfaction was
achieved. However, it would be unfair to provide this
well-evaluated service if it were only for an interim
period. Whether these services are sustainable over a
long period of time remains to be seen, due to issues
surrounding cost-eﬀectiveness and continuing changes
in healthcare politics. Yet, the general principle of
moving chronically ill patients from secondary to a
primary care setting reﬂects current changes in health-
care provision.
From the data ﬁndings, participants felt that the
most eﬀective way to deliver care for patients with
potential rheumatological conditions was at the inter-
face of primary/secondary care as provided by this new
service. Careful consideration has been given to these
ﬁndings, as they have the potential to impact signiﬁ-
cantly on chronic disease services. Further larger studies
are needed in order to develop sustainable services for
chronically ill patients.
Conclusion
Patients with suspected inﬂammatory arthritis require
rapid assessment, diagnosis and treatment. The com-
mencement of appropriate medication has been
proven to slow down disease progression and main-
tains quality of life. Unfortunately, current rheuma-
tology services struggle to provide treatment within a
set time period, thus leaving patients without the
required drug therapy. The rheumatology Tier 2 service
has improved not only care pathways thus reducing
inappropriate secondary care referrals but more im-
portantly the speed of the initial assessment, diagnosis
and treatment.
ETHICS COMMITTEE
Ethical approval was gained from Oldham Local
Research Ethics Committee and The University of
Salford.
REFERENCES
1 Department ofHealth. Supporting Peoplewith LongTerm
Conditions. An NHS and social care model to support local
innovation and integration. London: HMSO, 2005.
2 Arthritis and Musculoskeletal Alliance. Standards of
Care for People with Musculoskeletal Conditions. Avail-
able at: www.arma.uk.net (accessed 24November 2006).
3 QuinnMA,Conaghan PG and Emery P. The therapeutic
approach of early intervention for rheumatoid arthritis:
what is the evidence? Rheumatology 2001;40:1211–20.
4 Hochberg MC. Early aggressive DMARD therapy: the
key to slowing disease progression in rheumatoid arth-
ritis. Scandinavian Journal of Rheumatology 1999;28:3–7.
5 Irvine S,Munro R and Porter D. Early referral, diagnosis
and treatment of rheumatoid arthritis: evidence for a
changing practice. Annals of Rheumatic Disease 1999;58:
510–13.
6 Hewlett S, Mitchell K, Haynes J et al. Patient-initiated
hospital follow-up for rheumatoid arthritis. Rheuma-
tology 2000;29:990–7.
7 Hetthen J and Helliwell PS. A comparison between
primary care-led rheumatology services and secondary
care provision. Rheumatology 1999;38:1294–5.
8 Strauss A and Corbin J. Basics of Qualitative Research:
techniques and procedures for developing grounded theory
(2e). Thousand Oaks: Sage, 1998.
9 Artinian BA. Qualitative modes of inquiry. Western
Journal of Nursing Research 1998;10:138–49.
10 Buckley CD. Science, medicine and the future. Treat-
ment of rheumatoid arthritis. British Medical Journal
1997;315:236–8.
11 The University of York. Cost Eﬀectiveness Matters: The
NHS Economic Evaluation Database. 2002:6(1).
CONFLICTS OF INTEREST
None.
ADDRESS FOR CORRESPONDENCE
Sarah Critchley, Rheumatology Department, Out-
patients B, The Royal Oldham Hospital, Rochdale
Road, Oldham OL1 2JH, UK. Tel: +44 (0)161 295
7280; email: Sarah.Critchley@pat.nhs.uk
Received 18 July 2006
Accepted 8 November 2006
